Funder: Dept. of the Army -- USAMRAA

Due Dates: June 6, 2025 (Pre-application) | August 27, 2025 (Full application)

Funding Amounts: Up to $840,000 total costs per award over 2 years; ~12 awards; $10.08M total program funding.

Summary: Supports innovative, high-risk/high-gain research projects for ALS drug or therapy discovery that generate preliminary data for future therapeutic development.

Key Information: Pre-application required; focus must include biomarker development relevant to therapeutic strategy.